Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Federal Trade Commission
Fish and Richardson
McKesson
Healthtrust

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 10,182,984

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,182,984
Title:Targeted interferons demonstrate potent apoptotic and anti-tumor activities
Abstract: Novel chimeric moieties that show significant efficacy against cancers are provided. In certain embodiments the chimeric moieties comprise a targeting moiety attached to an interferon. In certain embodiments, the chimeric moieties comprise fusion proteins where an antibody that specifically binds to a cancer marker is fused to interferon alpha (IFN-.alpha.) or interferon beta (IFN-.beta.).
Inventor(s): Morrison; Sherie L. (Los Angeles, CA), Huang; Tzu-Hsuan (Libertyville, IL), Xuan; Caiyun (Newton, MA)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:15/359,456
Patent Claims:see list of patent claims

Details for Patent 10,182,984

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial The Regents of the University of California (Oakland, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 10,182,984

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2009039409 Mar 26, 2009
United States of America 2010172868 Jul 08, 2010
United States of America 2010297076 Nov 25, 2010
United States of America 2011104112 May 05, 2011
United States of America 2014079668 Mar 20, 2014
United States of America 2017151342 Jun 01, 2017
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Medtronic
Cipla
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.